USD 0.01
(233.33%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 136.26 Thousand CAD | -52.68% |
2022 | 287.99 Thousand CAD | 49.8% |
2021 | 192.25 Thousand CAD | 20.64% |
2020 | 159.36 Thousand CAD | 2.0% |
2019 | 156.24 Thousand CAD | -53.48% |
2018 | 335.88 Thousand CAD | -76.83% |
2017 | 1.44 Million CAD | -6.06% |
2016 | 1.54 Million CAD | -37.71% |
2015 | 2.47 Million CAD | -29.17% |
2014 | 3.49 Million CAD | -25.12% |
2013 | 4.67 Million CAD | 40.16% |
2012 | 3.33 Million CAD | -6.36% |
2011 | 3.55 Million CAD | 115.74% |
2010 | 1.64 Million CAD | 44.02% |
2009 | 1.14 Million CAD | 23.02% |
2008 | 931.2 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 28.44 Thousand CAD | -11.4% |
2024 Q1 | 32.1 Thousand CAD | -15.24% |
2023 Q3 | 31.58 Thousand CAD | 1.53% |
2023 FY | 136.26 Thousand CAD | -52.68% |
2023 Q4 | 37.87 Thousand CAD | 19.92% |
2023 Q1 | 35.7 Thousand CAD | -19.48% |
2023 Q2 | 31.1 Thousand CAD | -12.89% |
2022 Q1 | 101.71 Thousand CAD | 16.99% |
2022 Q4 | 44.34 Thousand CAD | -43.64% |
2022 Q2 | 63.24 Thousand CAD | -37.82% |
2022 Q3 | 78.68 Thousand CAD | 24.42% |
2022 FY | 287.99 Thousand CAD | 49.8% |
2021 Q4 | 86.93 Thousand CAD | 129.21% |
2021 FY | 192.25 Thousand CAD | 20.64% |
2021 Q1 | 33.49 Thousand CAD | 0.0% |
2021 Q2 | 33.88 Thousand CAD | 1.17% |
2021 Q3 | 37.93 Thousand CAD | 11.93% |
2020 FY | 159.36 Thousand CAD | 2.0% |
2019 FY | 156.24 Thousand CAD | -53.48% |
2018 FY | 335.88 Thousand CAD | -76.83% |
2017 FY | 1.44 Million CAD | -6.06% |
2017 Q2 | 275.12 Thousand CAD | -23.42% |
2017 Q3 | 213.69 Thousand CAD | -22.33% |
2017 Q1 | 359.26 Thousand CAD | 5.96% |
2017 Q4 | 1.01 Million CAD | 374.92% |
2016 Q4 | 339.04 Thousand CAD | -1.56% |
2016 FY | 1.54 Million CAD | -37.71% |
2016 Q3 | 344.4 Thousand CAD | -18.99% |
2016 Q1 | 434.5 Thousand CAD | -45.68% |
2016 Q2 | 425.11 Thousand CAD | -2.16% |
2015 Q2 | 572.16 Thousand CAD | -1.89% |
2015 Q4 | 799.96 Thousand CAD | 53.27% |
2015 FY | 2.47 Million CAD | -29.17% |
2015 Q1 | 583.21 Thousand CAD | -25.64% |
2015 Q3 | 521.91 Thousand CAD | -8.78% |
2014 Q2 | 840.73 Thousand CAD | -20.36% |
2014 FY | 3.49 Million CAD | -25.12% |
2014 Q1 | 1.05 Million CAD | -15.97% |
2014 Q4 | 784.28 Thousand CAD | -3.99% |
2014 Q3 | 816.9 Thousand CAD | -2.83% |
2013 Q1 | 1.21 Million CAD | 5.71% |
2013 Q3 | 1 Million CAD | -16.2% |
2013 FY | 4.67 Million CAD | 40.16% |
2013 Q4 | 1.25 Million CAD | 25.2% |
2013 Q2 | 1.19 Million CAD | -1.39% |
2012 Q4 | 1.14 Million CAD | 62.27% |
2012 Q1 | 807.66 Thousand CAD | 157.83% |
2012 Q3 | 707.92 Thousand CAD | 5.9% |
2012 FY | 3.33 Million CAD | -6.36% |
2012 Q2 | 668.46 Thousand CAD | -17.23% |
2011 Q3 | 1 Million CAD | 29.77% |
2011 Q2 | 772.52 Thousand CAD | 9.9% |
2011 FY | 3.55 Million CAD | 115.74% |
2011 Q1 | 702.89 Thousand CAD | 31.36% |
2011 Q4 | -1.39 Million CAD | -239.31% |
2010 Q2 | 386.23 Thousand CAD | 9.86% |
2010 Q1 | 351.57 Thousand CAD | -18.01% |
2010 Q4 | 535.08 Thousand CAD | 41.97% |
2010 FY | 1.64 Million CAD | 44.02% |
2010 Q3 | 376.91 Thousand CAD | -2.41% |
2009 Q1 | 221.47 Thousand CAD | -11.88% |
2009 FY | 1.14 Million CAD | 23.02% |
2009 Q4 | 428.78 Thousand CAD | 97.4% |
2009 Q3 | 217.21 Thousand CAD | -21.89% |
2009 Q2 | 278.08 Thousand CAD | 25.56% |
2008 Q3 | 244.12 Thousand CAD | 0.0% |
2008 FY | 931.2 Thousand CAD | 0.0% |
2008 Q4 | 251.33 Thousand CAD | 2.95% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Avitar, Inc. | 3.56 Million USD | 96.182% |
Lattice Biologics Ltd. | - USD | -Infinity% |
Manhattan Scientifics, Inc. | 703 Thousand USD | 80.616% |
Urologix, Inc. | 10.09 Million USD | 98.65% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | 91.963% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | 78.53% |
CVR Medical Corp. | - USD | -Infinity% |
Össur hf. | 396.18 Million USD | 99.966% |
Össur hf. | 396.18 Million USD | 99.966% |
SS Innovations International, Inc. | 21.38 Million USD | 99.363% |
VMS Rehab Systems, Inc. | 63.63 USD | -214058.416% |
QHSLab, Inc. | 961.65 Thousand USD | 85.83% |
Bionovate Technologies Corp | - USD | -Infinity% |
BrainsWay Ltd. | 28.01 Million USD | 99.514% |
BioElectronics Corporation | 740.67 Thousand USD | 81.602% |
Hamilton Thorne Ltd. | 33.57 Million USD | 99.594% |
Theraclion SA | 7.43 Million USD | 98.168% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Positron Corporation | 1 Million USD | 86.472% |
Stratec SE | 46.32 Million USD | 99.706% |
AVITA Medical, Inc. | 80.77 Million USD | 99.831% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -13.062% |
Zecotek Photonics Inc. | 3.46 Million USD | 96.063% |
Wellstar International, Inc. | 1.79 Million USD | 92.407% |
EKF Diagnostics Holdings plc | 21.77 Million USD | 99.374% |
Escalon Medical Corp. | 5.25 Million USD | 97.405% |
Guided Therapeutics, Inc. | 3.49 Million USD | 96.099% |
Aurora Spine Corporation | 8.65 Million USD | 98.426% |
NewCardio, Inc. | 9.56 Million USD | 98.575% |
Vivos Inc. | 2.78 Million USD | 95.111% |
MicroPort Scientific Corporation | 1.04 Billion USD | 99.987% |
Kelyniam Global, Inc. | 2.27 Million USD | 94.011% |
REMSleep Holdings, Inc. | 1.01 Million USD | 86.573% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | 68.71% |
Nanomix Corporation | 8.36 Million USD | 98.371% |
IR-Med Inc. | 4.89 Million USD | 97.216% |
Wellness Center USA, Inc. | 1.29 Million USD | 89.474% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | 95.619% |
Lombard Medical, Inc. | 30.29 Million USD | 99.55% |
ALR Technologies Inc. | 6.33 Million USD | 97.849% |
Vycor Medical, Inc. | 1.27 Million USD | 89.316% |
Heart Tronics, Inc. | 14.46 Million USD | 99.058% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 33.984% |
SANUWAVE Health, Inc. | 14.15 Million USD | 99.037% |
Ingen Technologies, Inc. | 1.88 Million USD | 92.76% |
United American Healthcare Corporation | 59 Thousand USD | -130.964% |
Odyssey Group International, Inc. | -14.26 Million USD | 100.956% |
ECGI Holdings, Inc. | 407.48 Thousand USD | 66.559% |
Polarean Imaging plc | 12.24 Million USD | 98.887% |
Medical Supply International USA, Inc. | 1.32 Million USD | 89.68% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 89.214% |
Nexeon MedSystems Inc. | 5.94 Million USD | 97.709% |
Qualis Innovations, Inc. | 230.24 Thousand USD | 40.815% |
Smith & Nephew plc | 3.46 Billion USD | 99.996% |
NIOX Group Plc | 22.27 Million USD | 99.388% |
Fuse Medical, Inc. | 10.35 Million USD | 98.683% |
Broncus Holding Corporation | 38.15 Million USD | 99.643% |
Brain Scientific Inc. | 9.66 Million USD | 98.59% |
Pressure BioSciences, Inc. | 10.3 Million USD | 98.677% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -124.503% |